• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Risk Factors for Severe COVID-19 in Children

tetano

Editor, Senior Moderator
Pediatrics


. 2021 Dec 22;e2021053418.
doi: 10.1542/peds.2021-053418. Online ahead of print.
Risk Factors for Severe COVID-19 in Children


Rebecca C Woodruff[SUP] 1 2 [/SUP], Angela P Campbell[SUP] 1 [/SUP], Christopher A Taylor[SUP] 1 [/SUP], Shua J Chai[SUP] 2 3 4 [/SUP], Breanna Kawasaki[SUP] 5 [/SUP], James Meek[SUP] 6 [/SUP], Evan J Anderson[SUP] 7 8 9 [/SUP], Andy Weigel[SUP] 10 [/SUP], Maya L Monroe[SUP] 11 [/SUP], Libby Reeg[SUP] 12 [/SUP], Erica Bye[SUP] 13 [/SUP], Daniel M Sosin[SUP] 14 15 [/SUP], Alison Muse[SUP] 16 [/SUP], Nancy M Bennett[SUP] 17 [/SUP], Laurie M Billing[SUP] 18 [/SUP], Melissa Sutton[SUP] 19 [/SUP], H Keipp Talbot[SUP] 20 [/SUP], Keegan McCaffrey[SUP] 21 [/SUP], Huong Pham[SUP] 1 [/SUP], Kadam Patel[SUP] 1 22 [/SUP], Michael Whitaker[SUP] 1 [/SUP], Meredith L McMorrow[SUP] 1 2 [/SUP], Fiona P Havers[SUP] 1 2 [/SUP]



Affiliations

Abstract

Objectives: Describe population-based rates and risk factors for severe coronavirus disease 2019 (COVID-19) (ie, ICU admission, invasive mechanical ventilation, or death) among hospitalized children.
Methods: During March 2020 to May 2021, the COVID-19-Associated Hospitalization Surveillance Network identified 3106 children hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection in 14 states. Among 2293 children primarily admitted for COVID-19, multivariable generalized estimating equations generated adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) of the associations between demographic and medical characteristics abstracted from medical records and severe COVID-19. We calculated age-adjusted cumulative population-based rates of severe COVID-19 among all children.
Results: Approximately 30% of hospitalized children had severe COVID-19; 0.5% died during hospitalization. Among hospitalized children aged <2 years, chronic lung disease (aRR: 2.2; 95% CI: 1.1-4.3), neurologic disorders (aRR: 2.0; 95% CI: 1.5‒2.6), cardiovascular disease (aRR: 1.7; 95% CI: 1.2‒2.3), prematurity (aRR: 1.6; 95% CI: 1.1‒2.2), and airway abnormality (aRR: 1.6; 95% CI: 1.1‒2.2) were associated with severe COVID-19. Among hospitalized children aged 2 to 17 years, feeding tube dependence (aRR: 2.0; 95% CI: 1.5‒2.5), diabetes mellitus (aRR: 1.9; 95% CI: 1.6‒2.3) and obesity (aRR: 1.2; 95% CI: 1.0‒1.4) were associated with severe COVID-19. Severe COVID-19 occurred among 12.0 per 100 000 children overall and was highest among infants, Hispanic children, and non-Hispanic Black children.
Conclusions: Results identify children at potentially higher risk of severe COVID-19 who may benefit from prevention efforts, including vaccination. Rates establish a baseline for monitoring changes in pediatric illness severity after increased availability of COVID-19 vaccines and the emergence of new variants.
 
Back
Top Bottom